• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MENAQUINONE 4
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION & THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ADROPIN
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • ADDICTION & DOPAMINE
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • ANXIOLYTIC
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BIOMIMETIC HYDROXYAPATITE
      • BMI-1
      • BPA & OBESITY
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CDK5
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DEPERSONALIZATION
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENDOCRINE DISRUPTING CHEMICALS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING & THE BRAIN
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUCOCORTICOID RECEPTOR ACTIVATION
      • GLUTAMATE & BRAIN
      • GLYCATION
      • GUT BRAIN AXIS
      • KLOTHO
      • K OPIOD RECEPTOR & ADDICTION
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HAIR REPIGMENTATION
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERALGESIA
      • HYPERINSULINEMIA
      • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INSULIN OXIDATIVE STRESS
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR & FEAR
      • NON OPIOD ANALGESICS
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • OBESOGENS
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SEX HORMONE BINDING GLOBULIN
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • THROMBOLYTICS (PLANT BASED)
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
      • XENOBIOTICS
      • XENOESTROGEN
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    COLD SHOCK PROTEINS
    February 21, 2022
    NOREPINEPHRINE
    February 21, 2022
    1. Hematopoietic Stem cell exhaustion impacted by p18INK4C and p21Cip1/Waf1 in opposite manners
    2. mTOR mediates Wnt-induced epidermal Stem cell exhaustion and aging
    3. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis
    4. The Polycomb group gene Ezh2 prevents hematopoietic Stem cell exhaustion
    5. Relationships between Stem cell exhaustion , tumour suppression and ageing
    6. Stem cell exhaustion and leukemogenesis
    7. Progeria of Stem cells: Stem cell exhaustion in Hutchinson-Gilford progeria syndrome
    8. Short telomeres and Stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice
    9. Genetic regulation of hematopoietic Stem cell exhaustion during development and growth
    10. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal Stem cell exhaustion syndromes?
    11. … ‐up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic Stem cell exhaustion
    12. Pre-CFU-S quiescence and Stem cell exhaustion after cytostatic drug treatment: protective effects of the inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK)
    13. … be the intracellular determinants of longevity implicated in the progeric influence of obesity: Insulin, IGF-1, and leptin may all conspire to promote Stem cell exhaustion
    14. Stem cell exhaustion and atherosclerosis
    15. Hematopoietic Stem cell Quiescence Maintained by p21cip1/waf1
    16. Stem cell aging: what bleach can teach
    17. Growth signaling at the nexus of Stem cell life and death
    18. p21 loss compromises the relative quiescence of forebrain Stem cell proliferation leading to exhaustion of their proliferation capacity
    19. Stem cells and the rate of living
    20. DNA repair is limiting for haematopoietic Stem cells during ageing
    21. A Limited Role for p21Cip1/Waf1 in Maintaining Normal Hematopoietic Stem cell Functioning
    22. Deconstructing Stem cell self-renewal: genetic insights into cell -cycle regulation
    23. Does Stem cell exhaustion result from combining hematopoietic
    24. Signaling circuitries controlling Stem cell fate: to be or not to be
    25. Epigenetic control of hematopoietic Stem cell aging the case of Ezh2
    26. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis
    27. The p53 tumor suppressor protein is a critical regulator of hematopoietic Stem cell behavior
    28. Loss of Foxo3a In FA Mice Leads to Hematopoietic Stem cell exhaustion That Can Be Attenuated by Natural Anti-Oxidant Quercetin.
    29. Understanding the Impact of Inflammation on Hematopoietic Stem Cells.
    30. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and Stem cell loss
    31. Accumulation of DNA damage in hematopoietic Stem and progenitor cells during human aging
    32. Cellular aging leads to functional heterogeneity of hematopoietic Stem cells: a modeling perspective
    33. Balancing dormant and self-renewing hematopoietic Stem cells
    34. Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased Stem cell turnover
    35. Controlling Stem cell proliferation: CKIs at work
    36. Cellular memory and hematopoietic Stem cell aging
    37. Enrichment of hematopoietic Stem cells with SLAM and LSK markers for the detection of hematopoietic Stem cell function in normal and Trp53 null mice
    38. Impaired hematopoietic Stem cell functioning after serial transplantation and during normal aging
    39. A dual role of p21 in Stem cell aging
    40. Mechanisms of Stem cell ageing
    41. Intrinsic and extrinsic control of haematopoietic Stem–cell self-renewal
    42. Runx family genes, niche, and Stem cell quiescence
    43. The haematopoietic Stem cell niche: new insights into the mechanisms regulating haematopoietic Stem cell behaviour
    44. Advances in hematopoietic Stem cell research through mouse genetics
    45. DNA repair is crucial for maintaining hematopoietic Stem cell function
    46. Regulation of hematopoietic Stem cell aging in vivo by a distinct genetic element
    47. Impaired Stem cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide, and G-CSF
    48. Peripheral Stem cell mobilization and engraftment in patients over age 60
    49. The chiaroscuro Stem cell : a unified Stem cell theory
    50. Quiescence regulators for hematopoietic Stem cell
    51. Hematopoietic Stem cell aging and self-renewal
    52. Etiology of limbal Stem cell transplantation failure
    53. DNA repair in Stem cell maintenance and conversion to cancer Stem cells
    54. Repopulating defect of mismatch repair–deficient hematopoietic Stem cells
    55. Genetic Uncoupling of the Regulation of Hematopoietic Stem cell Quiescence and Self-Renewal.
    56. MicroRNA miR-125a controls hematopoietic Stem cell number
    57. The nuclear receptor tailless induces long-term neural Stem cell expansion and brain tumor initiation
    58. Marrow aplasia developing 3 years after treatment with busulphan for chronic myeloid leukaemia
    59. Loss of proliferative capacity in immunohemopoietic Stem cells caused by serial transplantation rather than aging.
    60. Breaking the cell cycle of HSCs by p57 and friends
    61. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
    62. Mechanisms of hematopoietic Stem cell aging
    63. Failure of ocular surface reconstruction with amniotic membrane transplantation and living-related conjunctival limbal allograft
    64. Mechanisms that mediate Stem cell self‐renewal and differentiation
    65. Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells VI, University of Tübingen, Germany, September 14–16, 2006
    66. Live and let die: in vivo selection of gene-modified hematopoietic Stem cells via MGMT-mediated chemoprotection
    67. Clonal escape in Fanconi anemia: new hurdle for gene therapy?
    68. Aging of Hematopoietic Stem Cells LM Kamminga, R. van Os, A. Ausema, B. Dontje, G. DE HAAN
    69. Stem cell GENETICS AND GENOMICS: CONCISE REVIEW
    70. Identification of additional genetic alterations in RUNX1 related leukemias
    71. Simultaneous Maintenance of Human Cord Blood SCID‐Repopulating Cells and Expansion of Committed Progenitors at Low O2 Concentration (3%)
    72. How Stem cells age and why this makes us grow old
    73. Minimal residual disease and discontinuation of therapy in chronic myeloid leukemia: can we aim at a cure?
    74. Delayed mammary gland development in the p53+/m mouse, a model of accelerated aging
    75. Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia.
    76. cell cycle entry of hematopoietic Stem and progenitor cells controlled by distinct cyclin-dependent kinase inhibitors
    77. The elements of Stem cell self-renewal: a genetic perspective
    78. Adult Stem cell maintenance and tissue regeneration in the ageing context: the role for A‐type lamins as intrinsic modulators of ageing in adult Stem cells and their …
    79. Iron overload and haematopoiesis in MDS: does blood transfusion promote progression to AML?
    80. Metabolic rate determines haematopoietic Stem cell self-renewal
    81. Vascular aging: insights from studies on cellular senescence, Stem cell aging, and progeroid syndromes
    82. Pivotal role for glycogen synthase kinase–3 in hematopoietic Stem cell homeostasis in mice
    83. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic Stem cells
    84. Hematopoietic Support by Endothelium
    85. Maintenance of quiescent hematopoietic Stem cells in the osteoblastic niche
    86. Germline Stem Cells: The First Guards of Heredity
    87. Cancer Stem cells and “Stemness” genes in neuro-oncology
    88. Granulocyte colony stimulating factor for bone marrow transplantation
    89. Deciphering the signaling pathways of cancer Stem cells of glioblastoma multiforme: role of Akt/mTOR and MAPK pathways.
    90. Aplastic anaemia: considerations on the pathogenesis
    91. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal Stem cell defects
    92. Age-Adjusted Telomere Length Is Not Associated with Variation in Hematological Parameters in Ageing Women
    93. Ewing sarcoma gene Ews regulates hematopoietic Stem cell senescence
    94. Notch signaling is required to maintain all neural Stem cell populations–irrespective of spatial or temporal niche
    95. A conundrum in mammalian hematopoietic Stem cell polarity
    96. CAMT: new findings and new questions
    97. cell cycle regulators in Stem cells
    98. Musashi1: a Stem cell marker no longer in search of a function
    99. The CDK inhibitors: potential targets for therapeutic Stem cell manipulations?
    100. Therapeutic targeting of a Stem cell niche
    101. Lessons learned from the study of JunB: new insights for normal and leukemia Stem cell biology
    102. The MicroRNA pathway plays a regulatory role in Stem cell division
    103. Transcriptional activators, repressors, and epigenetic modifiers controlling hematopoietic Stem cell development
    104. HOXB4 overexpression mediates very rapid Stem cell regeneration and competitive hematopoietic repopulation
    105. p53 regulates hematopoietic Stem cell quiescence
    106. Regulation of hematopoietic Stem cells by the steel factor/KIT signaling pathway
    107. Hematopoietic Stem cells and the genetics of aging
    108. Stem cells and aging in the hematopoietic syStem
    109. Wnt signaling in the niche enforces hematopoietic Stem cell quiescence and is necessary to preserve self-renewal in vivo
    110. The role of the chromatin remodeler Mi-2β in hematopoietic Stem cell self-renewal and multilineage differentiation
    111. Adult Stem cell therapy beyond haemopoietic Stem cell transplantation? An update
    112. Calmodulin-dependent Protein Kinase IV Regulates Hematopoietic Stem cell Maintenance*♦
    113. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to Stem cell renewal and …
    114. Cdc42: a signal coordinator in hematopoietic Stem cell maintenance
    115. Thioredoxin-interacting protein regulates hematopoietic Stem cell quiescence and mobilization under stress conditions
    116. Epigenetic regulation of Stem cells in cancer and aging
    117. IL‐3 and peripheral blood Stem cell harvesting
    118. Stem cell ageing: does it happen and can we intervene?
    119. Stem cell factor enhances dendritic cell development
    120. Effect of Stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone …
    121. Prolonged cell cycle transit is a defining and developmentally conserved hemopoietic Stem cell property
    122. Stem–cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
    123. Stem cell injury and premature senescence
    124. Haemopoietic Stem cell inhibition: Potential for dose intensification
    125. JunB protects against myeloid malignancies by limiting hematopoietic Stem cell proliferation and differentiation without affecting self-renewal
    126. Genistein induces radioprotection by hematopoietic Stem cell quiescence
    127. Peripheral Stem cell mobilization and engraftment in patients over age 60
    128. PTEN negatively regulates neural Stem cell self-renewal by modulating G0-G1 cell cycle entry
    129. Ionizing radiation and aging: rejuvenating an old idea
    130. The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other Stem/progenitor cell populations
    131. Effects of prior therapy on the in vitro proliferative potential of Stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
    132. DNA repair defects in Stem cell function and aging
    133. DNA damage response in adult Stem cells: pathways and consequences
    134. Telomere dysfunction induces environmental alterations limiting hematopoietic Stem cell function and engraftment
    135. Survival analysis of conjunctival limbal grafts and amniotic membrane transplantation in eyes with total limbal Stem cell deficiency
    136. Fanconi anemia Stem cells: going round and round
    137. Hematopoietic Stem cell self-renewal
    138. Polycomb group genes: keeping Stem cell activity in balance
    139. Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes Stem cell reserve for …
    140. Dedifferentiation rescues senescence of progeria cells but only while pluripotent
    141. Notch signaling in the regulation of Stem cell self-renewal and differentiation
    142. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition
    143. Decline in self-renewal factors contributes to aging of the Stem cell niche in the Drosophila testis
    144. YY1 PcG function as a potential cancer therapeutic target
    145. Stem cell proliferation and quiescence—two sides of the same coin
    146. Awakening dormant haematopoietic Stem cells
    147. c-Myc controls the balance between hematopoietic Stem cell self-renewal and differentiation
    148. Multi-genetic events collaboratively contribute to Pten-null leukaemia Stem–cell formation
    149. Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance
    150. Latent hematopoietic Stem cell toxicity associated with protracted drug administration
    151. Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic Stem cells
    152. Hematopoietic Stem cell development, aging and functional failure
    153. Bone marrow-derived cells: the influence of aging and cellular senescence
    154. Effects of dietary restriction on hematopoietic Stem–cell aging are genetically regulated
    155. p16INK4a and Stem cell Ageing: A Telomere-Independent Process?
    156. FILAMENTARY KERATITIS-A REVIEW OF ETIOP A REVIEW OF ETIOPATHOGENESIS AND MANAGEMENT THOGENESIS AND MANAGEMENT
    157. Limiting factors in murine hematopoietic Stem cell assays
    158. Pbx1 regulates self-renewal of long-term hematopoietic Stem cells by maintaining their quiescence
    159. Telomere dysfunction and Stem cell ageing
    160. The daunting task of modeling response to imatinib therapy in patients with chronic myelogenous leukemia
    161. Telomeres and telomerase in cancer Stem cells
    162. Pten deletion in adult neural Stem/progenitor cells enhances constitutive neurogenesis
    163. Endothelial progenitor cell mobilization after percutaneous coronary intervention
    164. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic Stem cells
    165. Tissue engineering of the cornea
    166. Intrinsic control of Stem cell fate
    167. Effects of Prior Therapy on the in Vitro Proliferative Potential of Stem cell Factor Plus Filgrastim-mobilized CD34-positive Progenitor Cells1
    168. Hematopoiesis: an evolving paradigm for Stem cell biology
    169. The pessimist’s and optimist’s views of adult neurogenesis
    170. Mechanisms controlling hematopoietic Stem cell functions during normal hematopoiesis and hematological malignancies
    171. Mouse Model: Telomeres and Telomerase in Stem cell and Cancer
    172. Stem cell model of hematopoiesis
    173. Goralatide (AcSDKP), a negative growth regulator, protects the Stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM‐CSF
    174. A risk-benefit assessment of epoetin in the management of anaemia associated with cancer
    175. Compartmentalized organization: a common and required feature of Stem cell niches?
    176. Tuning mTORC1 activity for balanced self-renewal and differentiation
    177. Gene therapy approaches for Stem cell protection
    178. Loss of the Rho GTPase activating protein p190-B enhances hematopoietic Stem cell engraftment potential
    179. Hematopoietic Stem cells and aging
    180. HEMATOPOIETIC Stem cell TRANSFER: LBNT1 VIRUS VECTORS
    181. The stromal cells’ guide to the Stem cell universe
    182. Regulation of murine hematopoietic Stem cell quiescence by Dmtf1
    183. Signaling through BMPR-IA regulates quiescence and long-term activity of neural Stem cells in the adult hippocampus
    184. Tumor suppressor dosage regulates Stem cell dynamics during aging
    185. Mesenchymal Stem cell transplantation for tissue repair
    186. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
    187. Telomeres in hematopoietic Stem cells
    188. Regulation of Stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with …
    189. The roles of EZH2 in cell lineage commitment
    190. Hematopoietic Stem cell aging: wrinkles in Stem cell potential
    191. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition
    192. Genomic instability in induced Stem cells
    193. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
    194. Human skin Stem cells and the ageing process
    195. Polycomb repressive complex 2 is dispensable for maintenance of embryonic Stem cell pluripotency
    196. Ontogenic growth of the haemopoietic Stem cell pool in humans
    197. Inside Blood: a roadmap to the best and brightest
    198. A low level of reactive oxygen species selects for primitive hematopoietic Stem cells that may reside in the low-oxygenic niche
    199. Stem cells, DNA damage, ageing and cancer
    200. Hematopoietic Stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family
    201. Polycomb repressive complex 2 (PRC2) restricts hematopoietic Stem cell activity
    202. Maintenance of adult Stem cells: Role of the Stem cell niche
    203. The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic Stem cells
    204. Metabolic regulation of hematopoietic Stem cells in the hypoxic niche
    205. Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell -cycle arrest
    206. Ci er chun he duan li yu qing jiang yu Oryzias melastigma shou ming de xiang guan xing yan jiu
    207. Clonal diversity of the Stem cell compartment
    208. Rac1 is required for epithelial Stem cell function during dermal and oral mucosal wound healing but not for tissue homeostasis in mice
    209. Manifestations and mechanisms of Stem cell aging
    210. 6 2 6 Editorials The Journal of Pediatrics November 1996
    211. Age-specific bone tumour incidence rates are governed
    212. Autologous limbal transplantation in unilateral chemical burns
    213. Tracking down the Stem cells of the intestine: strategies to identify adult Stem cells
    214. Gfi-1: another piece in the HSC puzzle
    215. Polycomb group proteins: multi-faceted regulators of somatic Stem cells and cancer
    216. Toward ‘SMART’Stem cells
    217. Expression of Stem cell markers on mononuclear cells derived from heparinized cadaveric organ donors before and after disconnection from the respirator
    218. Handbook on Immunosenescence: Basic Understanding and Clinical Applications
    219. Understanding cellular networks to improve hematopoietic Stem cell expansion cultures
    220. Regulation of Self-Renewing Divisions in Normal and Leukaemia Stem Cells
    221. Using naturally occurring tumours in dogs and cats to study telomerase and cancer Stem cell biology
    222. Impaired PBPC collection in patients with myeloma after high-dose melphalan
    223. Human Stem cell engraftment in sheep
    224. Transplantation of hematopoietic Stem cells from the peripheral blood
    225. The molecular specificity of action of the tetrapeptide acetyl‐n‐ser‐asp‐lys‐pro (AcSDKP) in the control of hematopoietic Stem cell proliferation
    226. Altered mammary gland development in the p53+/m mouse, a model of accelerated aging
    227. Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates
    228. Plzf regulates germline progenitor self-renewal by opposing mTORC1
    229. Telomere attrition occurs during ex vivo expansion of human dental pulp Stem cells
    230. Rapamycin and quasi-programmed aging: Four years later
    231. At the Stem of youth and health
    232. Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic Stem cell function
    233. Hematopoietic Stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair
    234. cell cycle regulators in adult Stem cells
    235. Estimating dormant and active hematopoietic Stem cell kinetics through extensive modeling of bromodeoxyuridine label-retaining cell dynamics
    236. The p53–p66shc–manganese superoxide dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species
    237. Hemopoietic function after use of IL-1 with chemotherapy or irradiation
    238. A Stem cell fusion model of carcinogenesis.
    239. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
    240. Regulation of murine hematopoietic Stem cell quiescence by cyclin D binding myb-like transcription factor-1, Dmtf1
    241. Signaling pathways in self-renewing hematopoietic and leukemic Stem cells: do all Stem cells need a niche?
    242. Bone marrow Stem cell protection from chemotherapy by low–molecular-weight compounds
    243. Unraveling the complex regulation of Stem cells: implications for aging and cancer
    244. CD34 promotes satellite cell motility and entry into proliferation to facilitate efficient skeletal muscle regeneration
    245. 2010 International Forum on Stem Cells (November 11–13; Tianjin, China)
    246. The autophagy protein Atg7 is essential for hematopoietic Stem cell maintenance
    247. p53-mediated hematopoietic Stem and progenitor cell competition
    248. Pharmacological inhibition of EGFR signaling enhances G-CSF–induced hematopoietic Stem cell mobilization
    249. Sustained activation of mTOR pathway in embryonic neural Stem cells leads to development of tuberous sclerosis complex-associated lesions
    250. Runx1 loss minimally impacts long-term hematopoietic Stem cells
    251. Sirolimus and tacrolimus binding proteins: double-edged swords for GVHD prophylaxis
    252. In vivo selection using a cell -growth switch
    253. Mesenchymal Stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth
    254. Telomeres and Telomerase
    255. Tracking adult Stem cells
    256. The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal Stem cell niche
    257. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer
    258. Telomere biology in hematopoiesis and Stem cell transplantation
    259. Evaluation and eligibility of HLA‐identical sibling donors for Stem cell /bone marrow donation
    260. Ontogeny-related changes in proliferative potential of human hematopoietic cells.
    261. Establishment of an aging model of Sca-1+ hematopoietic Stem cell and studies on its relative biological mechanisms
    262. Modern genome-wide genetic approaches to reveal intrinsic properties of Stem cells
    263. Hematopoietic Stem cell Aging and Fate Decision
    264. Epithelial Stem cells: An epigenetic and wnt‐centric perspective
    265. Marked telomere fluctuation of leukocytes during graft-versus-host disease in allogeneic Stem cell transplantation
    266. Macrophage Inflammatory Protein-1α and Stem cell Inhibition
    267. Hematopoietic Stem cell Aging and Fate Decision
    268. Cytokine-mediated expansion does not deplete cord blood cells with Stem cell characteristics
    269. Ways of minimising hematopoietic damage induced by radiation and cytostatic drugs—the possible role of inhibitors
    270. Hematopoietic Stem cell emergence in embryonic life: developmental hematology revisited
    271. Cancer therapy-induced residual bone marrow injury: mechanisms of induction and implication for therapy
    272. Hayflick’s hypothesis: an approach to in vivo testing
    273. Expansion of LTC-ICs and Maintenance of p21 and BCL-2 Expression in Cord Blood CD34+/CD38− Early Progenitors Cultured over Human MSCs as a Feeder …
    274. Haemoprotection against cytostatic drugs by Stem cell inhibition
    275. All-trans retinoic acid induces proliferation of an irradiated Stem cell supporting stromal cell line AFT024
    276. Progress in the development of syStems for in vitro expansion of human hematopoietic Stem cells
    277. Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood Stem cell transplantation
    278. From tissue turnover to the cell of origin for pancreatic cancer
    279. Hematopoietic Stem cells: generation and self-renewal
    280. Improved outcome following allogeneic Stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune …
    281. Hematopoietic progenitor/Stem cells immortalized byLhx2 generate functional hematopoietic cells in vivo
    282. Hematopoiesis from human embryonic Stem cells
    283. Current concepts in the pathophysiology and treatment of aplastic anemia
    284. Do we have to kill the last CML cell ?
    285. High‐dose therapy with peripheral blood Stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment
    286. cell death by sugar: Bittersweet TOR
    287. Fanconi anaemia: new strategies
    288. Aplastic anemia: pathogenesis and treatment
    289. Epigenetic modifications of Stem cells: a paradigm for the control of cardiac progenitor cells
    290. Splenic primitive hematopoietic Stem cell (PHSC) activity is enhanced by steel factor because of PHSC proliferation
    291. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis
    292. Rapamycin and other longevity‐promoting compounds enhance the generation of mouse induced pluripotent Stem cells
    293. The microRNA cluster miR-106b~ 25 regulates adult neural Stem/progenitor cell proliferation and neuronal differentiation
    294. Stems cells and the pathways to aging and cancer
    295. The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult hematopoietic Stem cells
    296. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective …
    297. Polycomb silencers control cell fate, development and cancer
    298. In vivo radioprotective effect of AcSDKP on canine myelopoiesis
    299. Hypoxia-inducible factors and marrow stromal function
    300. Management of Acute Leukemia
    301. Polycomb group proteins in hematopoietic Stem cell aging and malignancies
    302. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations
    303. Posttransplant hematopoiesis in patients undergoing sibling allogeneic Stem cell transplantation reflects that of their respective donors although with a lower functional …
    304. Hematopoietic Stem cells are not the direct target of spontaneous leukemic transformation in p18INK4C-null reconstituted mice
    305. Stonewalling Drosophila Stem cell differentiation by epigenetic controls
    306. Hematopoietic Stem cell expansion
    307. The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic Stem cells
    308. The critical role of agrin in the hematopoietic Stem cell niche
    309. Fancd2 −/− mice have hematopoietic defects that can be partially corrected by resveratrol
    310. cell cycle and developmental control of hematopoiesis by Runx1
    311. Genotoxic stress abrogates renewal of melanocyte Stem cells by triggering their differentiation
    312. Gone with the Wnt/Notch: Stem cells in laminopathies, progeria, and aging
    313. Differentiation of neural Stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2
    314. Melanocyte Stem cells
    315. Hematopoietic Stem cells and the aging hematopoietic syStem
    316. In vivo T-cell dynamics during immune reconstitution after hematopoietic Stem cell gene therapy in adenosine deaminase severe combined immune deficiency
    317. Hemopoietic Function After Use of IL-1 with
    318. Genetic Regulation of Hematopoietic Stem cell Aging
    319. Wnt Signaling in the Niche Enforces Hematopoietic Stem cell Quiescence and Is Necessary to Preserve Self-Renewal…
    320. Pathophysiologic mechanisms in acquired aplastic anemia
    321. EWS-FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal Stem cells
    322. Shifting senescence into quiescence by turning up p53
    323. The Wnt receptor, Lrp5, is expressed by mouse mammary Stem cells and is required to maintain the basal lineage
    324. Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic Stem cells
    325. Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible …
    326. Cellular and Molecular Crossroads of Cancer and Aging
    327. Chaotic dynamic stabilities and instabilities of hematopoietic Stem cell growth plasticity
    328. Have We Reached the Point for In Vivo Rejuvenation?
    329. Developmental plasticity of Stem cells and diseases
    330. Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways
    331. Impact papers on aging in 2009
    332. Principles of hematopoietic Stem cell biology
    333. The t (6; 9) associated DEK/CAN fusion protein targets a population of long-term repopulating hematopoietic Stem cells for leukemogenic transformation
    334. GATA2 finds its macrophage niche
    335. Donor age and cell passage affects differentiation potential of murine bone marrow-derived Stem cells
    336. Hematopoietic Stem cells
    337. Reduced Proliferative Capacity of Hematopoietic Stem Cells Deficient in Hoxb3 and Hoxb4
    338. Roles of PPAR and p21WAF1/CIP1 in monocyte/macrophage differentiation: are circulating monocytes able to proliferate?
    339. The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseases
    340. Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units
    341. Transcription factor Gfi1 regulates self‐renewal and engraftment of hematopoietic Stem cells
    342. Wnt/β-catenin signaling induces the aging of mesenchymal Stem cells through the DNA damage response and the p53/p21 pathway
    343. cell divisions and mammalian aging: integrative biology insights from genes that regulate longevity
    344. Preservation of Hemopoietic Stem Cells
    345. Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression
    346. 10 Epigenetics in Cancer Stem cell Development
    347. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells
    348. Blood disorders in the elderly
    349. Normal Stem cells and cancer Stem cells: similar and different
    350. Attributes of adult Stem cells
    351. Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia
    352. Stem cell niches and other factors that influence the sensitivity of bone marrow to radiation-induced bone cancer and leukaemia in children and adults
    353. E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors
    354. Haploinsufficiency of SNEV causes defects of hematopoietic Stem cells functions
    355. The Future of Hematopoietic Growth Factors
    356. Telomere length in paroxysmal nocturnal hemoglobinuria correlates with clone size
    357. Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model
    358. Standardization of hematopoietic Stem cell assays: a summary of a workshop and working group meeting sponsored by the National Heart, Lung, and Blood Institute …
    359. Identification of Stem cell transcriptional programs normally expressed in embryonic and neural Stem cells in alloreactive CD8+ T cells mediating graft-versus …
    360. Inhibitors of haemopoiesis and their potential clinical relevance
    361. Aging Stem cells, latexin and longevity
    362. Sequential sectoral conjunctival epitheliectomy (SSCE)
    363. Activation of developmental signaling pathways in hematopoietic Stem cell regeneration
    364. Somatic and germline genetics at the JAK2 locus
    365. Kinetics of normal hematopoietic Stem and progenitor cells in a Notch1-induced leukemia model
    366. Rac1 Is Required for Epithelial Stem cell Function during Dermal and Oral
    367. MicroRNA profiling reveals age-dependent differential expression of nuclear factor κB and mitogen-activated protein kinase in adipose and bone marrow …
    368. Epigenetic regulation of satellite cell activation during muscle regeneration
    369. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome
    370. Essential biology of Stem cell transplantation
    371. Regulatory circuitries coordinated by transcription factors and microRNAs at the cornerstone of hematopoietic Stem cell self-renewal and differentiation
    372. Repopulating Activity of Ex Vivo‐Expanded Murine Hematopoietic Stem Cells Resides in the CD48−c‐Kit+Sca‐1+Lineage Marker− cell Population
    373. Retroviral expression of arginine decarboxylase attenuates oxidative burden in mouse cortical neural Stem cells
    374. A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia
    375. Searching for adult Stem cells in the intestine
    376. Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men
    377. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary Stem cells
    378. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic Stem cells in glioblastoma
    379. Growth factors and the molecular control of haematopoiesis
    380. BMI1 confers radioresistance to normal and cancerous neural Stem cells through recruitment of the DNA damage response machinery
    381. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic Stem cells
    382. Chromatin modulation by oncogenic transcription factors: new complexity, new therapeutic targets
    383. Hemopoietic alterations of cancer
    384. Clinical challenges and cord blood transplantation: are we asking the right questions?
    385. Life and death in hematopoietic Stem cells
    386. The hemoregulatory peptide pEEDCK may inhibit Stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth …
    387. Elucidating the role of metabolic factors in hematopoietic Stem cell maintenance
    388. Dysfunctional endothelial progenitor cells in chronic kidney disease
    389. Cancer Stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy
    390. Telomere length and proliferation potential of hematopoietic Stem cells
    391. Age, caste, and behavior determine the replicative activity of intestinal Stem cells in honeybees (Apis mellifera L.)
    392. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell -mediated gene therapy
    393. Aging and disease as modifiers of efficacy of cell therapy
    394. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms
    395. A Runx1 Intronic Enhancer Marks Hemogenic Endothelial Cells and Hematopoietic Stem Cells
    396. PROSPECT
    397. Differentiated cells are more efficient than adult Stem cells for cloning by somatic cell nuclear transfer
    398. Leukemia Stem Cells
    399. Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex
    400. Growth Factors Promote High-Dose Chemotherapy
    401. cell kinetics of CD34‐positive hematopoietic cells following chemotherapy plus colony‐stimulating factors in advanced breast cancer
    402. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone marrow failure disease scientific symposium 2010
    403. The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzene-induced hematopoietic toxicity
    404. Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation …
    405. Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice
    406. Investigating The Role Of Runx1 In Hair Follicle Stem cell Development And Homeostasis
    407. cell cycle, CDKs and cancer: a changing paradigm
    408. Protective effects of BB-10010 treatment on chemotherapy-induced neutropenia in mice
    409. The Paton Lecture: Ocular Surface Transplantation 10 Years’ Experience
    410. Idiopathic Aplastic Anemia
    411. Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia
    412. Growth factors and hematopoietic recovery
    413. 7 Growth inhibitors in haemopoiesis and leukaemogenesis
    414. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term culture-initiating cells of murine bone marrow …
    415. Granulocyte colony–stimulating factor administration: adverse events
    416. Stem cells and cancer: evidence for bone marrow Stem cells in epithelial cancers
    417. Shp-2 heterozygous hematopoietic Stem cells have deficient repopulating ability due to diminished self-renewal
    418. Leukemia Stem Cells, A Pioneering Paradigmatic Model
    419. Regulation of reactive oxygen species and genomic stability in hematopoietic Stem cells
    420. mTOR: from growth signal integration to cancer, diabetes and ageing
    421. Bone marrow failure syndromes
    422. Dyskerin, telomerase and the DNA damage response
    423. The road to commitment: lineage restriction events in hematopoiesis
    424. Skeletal muscle Stem cells: effects of aging and metabolism on muscle regenerative function
    425. 22 THE NORMAL BONE MARROW AND MANAGEMENT OF TOXIN-INDUCED Stem cell FAILURE
    426. Targeting leukemia Stem cells: The new goal of therapy in adult acute myeloid leukemia
    427. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1B β and TSLC1 in neuroblastoma
    428. cell cycle regulation in hematopoietic Stem cells
    429. HLA-matched living-related conjunctival limbal allograft for bilateral ocular surface disorders: long-term results
    430. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
    431. Phenotypic and Functional Changes in Cord Blood Stem cell Progeny after Cytokine Activation
    432. Lentiviral gene transfer regenerates hematopoietic Stem cells in a mouse model for Mpl-deficient aplastic anemia
    433. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF
    434. Conditional induction of the telomerase reverse transcriptase protein and effects on Stem cell division in vivo
    435. Replicative senescence and cell immortality: the role of telomeres and telomerase
    436. Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases
    437. Same‐day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation
    438. Deletion of Puma protects hematopoietic Stem cells and confers long-term survival in response to high-dose γ-irradiation
    439. Epigenetic therapy
    440. The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis
    441. Stem cells and cancer in the aerodigestive tract
    442. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells
    443. Leukemia Stem cells and new strategies to overcome resistance to therapy
    444. PUMA kills Stem cells to stall cancer?
    445. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features
    446. Growth factor changes in ex vivo expansion of human limbal epithelial cells on human amniotic membrane
    447. cell cycle control and check points in hematopoietic Stem cells
    448. Ovarian cancer plasticity and epigenomics in the acquisition of a Stem-like phenotype
    449. Practical Use of Hematopoietic Growth Factors in HIV Infection
    450. Novel Treatment Options
    451. Replicative senescence of mesenchymal Stem cells causes DNA-methylation changes which correlate with repressive histone marks
    452. Genetic Regulation of Hematopoietic Stem cell Numbers in Mice
    453. The biology of cancer Stem cells
    454. Self-renewal of primitive hematopoietic cells: a focus on asymmetric cell division
    455. The Tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Goralatide) Protects From
    456. 2006 Kent Award Lecture: Is cell death and replacement a factor in aging?
    457. Transcriptional and epigenetic regulation of B cell development
    458. Cigarette Smoke Triggers Code Red: p21CIP1/WAF1/SDI1 Switches on Danger Responses in the Lung
    459. cell Cycle-Related Changes in Repopulating Capacity of Human Mobilized Peripheral Blood CD34+ Cells in Non-Obese Diabetic/Severe Combined Immune …
    460. degree of Doctor of Philosophy (Ph. D.)
    461. Research on Hutchinson-Gilford progeria syndrome
    462. TOR-driven aging: speeding car without brakes
    463. Prolonged cell Cycle Transit Is a Defining
    464. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial …
    465. Mobilization of Peripheral Blood Stem Cells from Normal Donors
    466. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1high leukemia cells
    467. Mobilization and transplantation of peripheral blood Stem cells
    468. The role of telomere biology in bone marrow failure and other disorders
    469. Telomere biology of human hematopoietic Stem cells
    470. Haemopoietic defect and decreased expansion potential of bone marrow autografts from patients with acute myeloid leukaemia in first remission
    471. Wnt signaling regulates hepatic metabolism
    472. Epigenetic dysregulation in cancer
    473. The DNA-damage response in human biology and disease
    474. Pharmacologic Induction of CD8+ T cell Memory: Better Living Through Chemistry
    475. Mice severely deficient in growth hormone have normal hematopoiesis
    476. Erythropoiesis in murine long‐term bone‐marrow cell cultures: Dependence on erythropoietin and endogenous production of an erythropoietic stimulating activity
    477. Mobilization of Pheripheral Blood Stem Cells from Normal Donors
    478. Empowering adult Stem cells for myocardial regeneration
    479. Short-term injection of antiapoptotic cytokine combinations soon after lethal γ-irradiation promotes survival
    480. Overview of hemopoiesis and hemopoietic reconstruction
    481. Factors that may impact on immunosenescence: an appraisal
    482. Dietary Restriction: A Model SyStem Probing the cell Fate Decision Between Cancer and Senescence
    483. Lineage-specific hematopoietic growth factors
    484. Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer
    485. Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression
    486. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic Stem cells
    487. Functional analysis of the homeobox gene HOXB4 in primitive hematopoietic cells
    488. Changing concepts in the management of severe ocular surface disease over twenty-five years
    489. TGFβ signaling in male germ cells regulates gonocyte quiescence and fertility in mice
    490. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies
    491. Recurrence of aplastic anemia following cyclophosphamide and syngeneic bone marrow transplantation: evidence for two mechanisms of graft failure
    492. In Vitro Modifications Induced by Granulocyte-Macrophage Colony-Stimulating Factor in Human Long-Term Bone Marrow Cultures
    493. Mechanisms of Wnt-and Notch-mediated Stem cell self-renewal
    494. Cancer Stem cells: the emerging challenge of drug targeting
    495. An RbAp48-like gene regulates adult Stem cells in planarians
    496. GM-CSF multiple course priming and long-term administration in newly diagnosed acute myeloid leukemia: Comparison of three different GM-CSF routes and …
    497. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging
    498. Premeiotic germ cell defect in seminiferous tubules of Atm-null testis
    499. cell cycle regulators and hematopoiesis
    500. Quantitative analysis of mixed chimerism following allogeneic bone marrow transplantation using telomere flow-FISH
    501. Senescence and apoptosis in yeast mother cell -specific aging and in higher cells: a short review
    502. Bid is a positive regulator for donor-derived lymphoid cell regeneration in γ-irradiated recipients
    503. Peripheral blood progenitor cells versus bone marrow
    504. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow
    505. Transplante alogênico inter vivo de limbo conjuntival com pareamento HLA em doenças bilaterais da superfície ocular: resultados em longo prazo
    506. Activation of adenosine A3 receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice
    507. The biology and clinical uses of blood Stem cells
    508. The cell cycle regulator Cdh1 controls the pool sizes of hematopoietic Stem cells and mature lineage progenitors by protecting from genotoxic stress
    509. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience
    510. Craniofacial Reconstruction and Aging of Human Mesenchymal Stem Cells
    511. Principles of hematotoxicology: laboratory assessment and interpretation of data
    512. Telomere dynamics in hematopoietic Stem cells
    513. Characterisation of the leukemic Stem cell in a murine model of CALM/AF10 positive myeloid leukemia
    514. cell aging in relation to stress arousal and cardiovascular disease risk factors
    515. Cytokine receptors, growth factors and cell cycle in human bone marrow and peripheral blood hematopoietic progenitors
    516. A low level of reactive oxygen species selects for primitive hematopoietic
    517. RUNX1 regulates the CD34 gene in haematopoietic Stem cells by mediating interactions with a distal regulatory element
    518. Norc sIGNALLING Is REQUIRED FOR
    519. Additive effect of TAp63 deficiency on the adrenocortical dysplasia (acd) phenotype
    520. Protection and selection for gene therapy in the hematopoietic syStem
    521. Genetic variation in healthy oldest-old
    522. Haemopoietic Stem cells: their heterogeneity and regulation
    523. Age-related decline in immunity: implications for vaccine responsiveness
    524. Promiscuous and lineage-specific roles of cell cycle regulators in haematopoiesis
    525. Bone marrow CD34+ cells expanded on human brain endothelial cells reconstitute lethally irradiated baboons in a variable manner
    526. A Runx1-Smad6 rheostat controls Runx1 activity during embryonic hematopoiesis
    527. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
    528. Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects
    529. Mutations of mitochondrial DNA–cause or consequence of the ageing process?
    530. Efficacy of up-front 5-fluorouracil–epidoxorubicin–cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer …
    531. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation
    532. Adult-onset, short-term dietary restriction reduces cell senescence in mice
    533. The emerging roles of forkhead box (Fox) proteins in cancer
    534. Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic …
    535. The molecular mechanisms that control thrombopoiesis
    536. Hematopoietic Effect of Fractions from the Enzyme-Digested colla corii asini on Mice with 5-Fluorouracil Induced Anemia
    537. The Wnt Receptor
    538. Stem cells for skeletal muscle repair
    539. Three-month therapeutic effect of bone marrow mesenchymal Stem cells transplantation on the treatment of X-linked muscular distrophy mice
    540. The evolution and classification of ocular surface transplantation
    541. Hematopoietic Stem Cells and Somatic Stem Cells
    542. Prospective isolation and molecular characterization of hematopoietic Stem cells with durable self-renewal potential
    543. Pseudo-DNA damage response in senescent cells
    544. Interferon-γ and tumor necrosis factor-α differentially affect cytokine expression and migration properties of mesenchymal Stem cells
    545. CDKs and CKIs: molecular targets for tissue remodelling
    546. Clonality analysis of childhood ALL in remission: no evidence of clonal hematopoiesis
    547. Aryl hydrocarbon receptor-null allele mice have hematopoietic Stem/progenitor cells with abnormal characteristics and functions
    548. Biology of bone marrow-derived endothelial cell precursors
    549. Telomere dysfunction triggers developmentally regulated germ cell apoptosis
    550. Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents
    551. Issues in the clinical development of recombinant methionyl human granulocyte colony-stimulating factor: A review
    552. Telomeres and telomerase regulation
    553. Increased longevity of hematopoiesis in continuous bone marrow cultures derived from NOS1 (nNOS, mtNOS) homozygous recombinant negative mice correlates with …
    554. Macrophage Inflammatory Protein 1α Attenuates the Toxic Effects of Temozolomide in Human Bone Marrow Granulocyte-Macrophage Colony-forming Cells
    555. Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cells
    556. Radio-and chemoprotection of bone marrow cells by opposite cell cycle-acting cytokines
    557. Lineage-specific differences in telomere length after bone marrow transplantation
    558. Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia …
    559. DNA damage and cellular differentiation: more questions than responses
    560. Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)
    561. DNMT3b’s Role in Hematopoietic Stem Cells
    562. Opposing roles of polycomb repressive complexes in hematopoietic Stem and progenitor cells
    563. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal
    564. Macrophage Inflammatory Protein 1 Attenuates the Toxic Effects of Temozolomide in Human Bone Marrow Granulocyte-Macrophage Colony-forming Cells1
    565. Your use of the JSTOR archive indicates your acceptance of JSTOR’s Terms and Conditions of Use, available at
    566. Accelerated wound healing by mTOR activation in genetically defined mouse models
    567. Unexpected Proatherogenic Properties of p21
    568. Autophagy and aging
    569. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation
    570. The ageing epigenome: damaged beyond repair?
    571. Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling
    572. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development
    573. cell death in the nervous syStem
    574. In vivo haemoprotective activity of tetrapeptide AcSDKP combined with granulocyte‐colony stimulating factor following sublethal irradiation
    575. Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus
    576. A continuum model for tumour suppression
    577. Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic Stem cells
    578. Myelopoietic response in tumour-bearing mice by an aggregated polymer isolated from Aspergillus oryzae
    579. Overexpression of the MnSOD transgene product protects cryopreserved bone marrow hematopoietic progenitor cells from ionizing radiation
    580. Stimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae on murine haematopoietic Stem cells and megakaryocyte progenitors
    581. EWS-FLI-1 Expression Triggers a Ewing’s Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
    582. Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia
    583. Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration
    584. Aging of the Hematopoietic SyStem
    585. Specific roles of Target of rapamycin in the control of Stem cells and their progeny in the Drosophila ovary
    586. cell senescence: the future of ageing?
    587. Circadian‐based effects of AcSDKP, with or without rhG–CSF on hematologic toxicity of chemotherapy in mice
    588. Aging-associated decline in innate immunity and therapeutic strategies to counteract it
    589. Characterization of CD62L as a marker of hematopoietic differentiation in adult mice
    590. Canonical and non-canonical Wnt signaling in hematopoiesis and lymphocyte
    591. The Role of the DNA Mismatch Repair Pathway in Adult Stem Cells In Vivo
    592. Retroviral gene therapy in hematopoietic diseases
    593. Hematopoietic Stem cells: molecular diversification and developmental interrelationships
    594. Abnormalities of axon growth in human olfactory mucosa
    595. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells
    596. Unexpected proatherogenic properties of p21: beyond cell cycle control?
    597. Genetic modification of ex-vivo expanded Stem cells for clinical application
    598. Wnt/β-catenin signaling in normal and cancer Stem cells
    599. How transcription factors program chromatin—lessons from studies of the regulation of myeloid-specific genes
    600. Intra-articular injections in capsulitis
    601. Targeting malignant B cell self-renewal and differentiation
    602. Graft failure following allogeneic blood and marrow transplant: evidence-based nursing case study review
    603. Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model
    604. Molecular damage in cancer: an argument for mTOR-driven aging
    605. Intercellular feedback in hematopoiesis
    606. Acute myeloblastic leukemia and recombinant granulocyte colony stimulating factor.
    607. Retrospective Review of Odontogenic Infections at a Tertiary Medical Center: Clinical Correlations Based on Culture and Sensitivity Data
    608. As a matter of fat: new perspectives on the understanding of age-related bone loss
    609. Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathway
    610. Management of the hematologic manifestations of HIV disease
    611. Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis
    612. ANALYSIS/PROSPECTS
    613. Stromal pleiotrophin regulates repopulation behavior of hematopoietic Stem cells
    614. Physiological relevance of cell cycle kinases
    615. The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs
    616. Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide …
    617. Enrichment of functionally distinct mouse hematopoietic progenitor cell populations using CD62L
    618. Beta 2 agonists and asthma.
    619. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin’s lymphoma patients after combination chemotherapy and G-CSF
    620. Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis
    621. Towards cure of CML: why we need to know more about CML Stem cells?
    622. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
    623. The Role of Hox Transcription Factors in the Regulation of Hematopoiesis
    624. Highlights of the 2007 Progeria Research Foundation scientific workshop: progress in translational science
    625. KRASG12V enhances proliferation and initiates myelomonocytic differentiation in human Stem/progenitor cells via intrinsic and extrinsic pathways
    626. The molecular basis of cutaneous aging
    627. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
    628. Hyaluronic acid facilitates the recovery of hematopoiesis following 5‐fluorouracil administration
    629. Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage
    630. Diabetes induced changes in rat mesenchymal Stem cells
    631. Epigenetic corruption of VDR signalling in malignancy
    632. Intra-articular injections in capsulitis
    633. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against …
    634. B-lymphocyte commitment: identifying the point of no return
    635. Effects of recombinant human granulocyte colony‐stimulating factor on leucopenia in zidovudine‐treated patients with AIDS and AIDS related complex, a phase I/II …
    636. Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA)
    637. Ex vivo culture of Fancc-/- Stem/progenitor cells predisposes cells to undergo apoptosis, and surviving Stem/progenitor cells display cytogenetic abnormalities and an …
    638. Telomere length dynamics in normal and malignant hematopoiesis
    639. Hematopoietic growth factors in transplantation: Biology and applications
    640. Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice
    641. Recombinant human granulocyte colony-stimulating factor in the management of cancer patients: five years on
    642. Hematopoietic Stem cells
    643. Intrinsic and Microenvironmental Defects Are Involved in the Age-Related Changes of Lin−c-kit+ Hematopoietic Progenitor Cells
    644. Relationships between hematopoiesis and hepatogenesis in the midtrimester fetal liver characterized by dynamic transcriptomic and proteomic profiles
    645. Apoptotic regulation in primitive hematopoietic precursors
    646. Theories and mechanisms of aging
    647. 11 Blood compared to marrow as a source of allogeneic hematopoietic Stem cells for
    648. RUNX1 Mutations in Clonal Myeloid Disorders: From Conventional Cytogenetics to Next Generation Sequencing, A Story 40 Years in the Making
    649. Without Hemopoietic cell Support
    650. Human somatic mutation rate estimated from SNP chips
    651. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer
    652. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study
    653. EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence
    654. Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus
    655. The role of DNA damage and repair in aging: new approaches to an old problem
    656. Proliferation Society Meeting
    657. The polycomb gene BMI1 in normal hematopoiesis and leukemia
    658. The high functionalization of temperature-responsive culture dishes for establishing advanced cell sheet engineering
    659. Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphoma
    660. Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity
    661. PTEN loss in the continuum of common cancers, rare syndromes and mouse models
    662. Insulin signaling and life span
    663. Polycomb proteins in mammalian cell differentiation and plasticity
    664. The genetics of dyskeratosis congenita
    665. Stimulation of myelopoiesis in Lister a monocytogenes-infected mice by an aggregated polymer isolated from Asp ergillus oryzae
    666. High-efficiency retroviral gene transfer into murine high-proliferative-potential cells cycle-activated by cytosine arabinoside
    667. Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic …
    668. Emerin and the nuclear lamina in muscle and cardiac disease
    669. Radiation-induced Hemopoietic and Immune Dysfunction
    670. Telomere length in Hutchinson-Gilford progeria syndrome
    671. A Randomized Phase-II Study of BB-10010 (Macrophage Inflammatory Protein-1) in Patients With Advanced Breast Cancer Receiving 5-Fluorouracil, Adriamycin …
    672. Anemia, Paroxysmal Nocturnal Hemoglobinuria, Pure Red Blood cell
    673. Cancer Initiating Cells in Head and Neck Squamous cell Carcinoma
    674. Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes
    675. XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from Molecular Pathogenesis to Targeted Therapy in …
    676. An examination of ethical issues raised in the pretreatment of normal volunteer granulocyte donors with granulocyte colony-stimulating factor
    677. Telomere binding proteins including TRF1 and TRF2 (indicated by light and
    678. Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy
    679. Reduction in carboplatin hematopoietic toxicity in tumor bearing mice: comparative mechanisms and effects of interleukin-1β and corticosteroids
    680. Functions of Pleiotrophin in the Regulation of Hematopoiesis
    681. Therapy for Fanconi Anemia
    682. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches
    683. Hematopoietic growth factors in cancer treatment
    684. Ku, Artemis, and ataxia-telangiectasia-mutated: signalling networks in DNA damage
    685. Defective Notch activation in microenvironment leads to myeloproliferative disease
    686. Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in mdx Mice
    687. The role of haemopoietic growth factors in bone marrow transplantation
    688. The role of hematopoietic growth factors in small cell lung cancer: a review
    689. Pathophysiology and treatment of acquired
    690. Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity
    691. NCI’s provocative questions on cancer: some answers to ignite discussion
    692. Regulation of senescence in cancer and aging
    693. Telomere elongation followed by telomere length reduction, in leukocytes from divers exposed to intense oxidative stress–implications for tissue and organismal aging
    694. Diffuse plasmacytosis in a child with brainStem glioma following multiagent chemotherapy and intensive growth factor support
    695. The design of differentiation therapies
    696. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone …
    697. The p38 mitogen-activated protein kinase pathway in interferon signal transduction
    698. Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis
    699. The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS
    700. Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis, and aging
    701. Identification and Characterization of Tumour Initiating Cells From Gynaecological Malignancies
    702. Pretreatment with granulocyte colony-stimulating factor reduces myelopoiesis in irradiated mice
    703. Effects of adenosine A3 receptor agonist on bone marrow granulocytic syStem in 5-fluorouracil-treated mice
    704. Biology of the Mi-2/NuRD complex in SLAC (Stemness, longevity/ageing, and cancer)
    705. Frequency Analysis of Multidrug Resistance-1 Gene Transfer into Human Primitive Hematopoietic Progenitor Cells Using the Cobblestone Area-Forming cell Assay …
    706. Epigenetic factors in cancer development: polycomb group proteins
    707. Genomic instability in incuded Stem cells and regulation of P14ARF expression
    708. Final checkup of neoplastic DNA replication: Evidence for failure in decision-making at the mitotic cell cycle checkpoint G1/S
    709. Transient monoparesis following blade plate removal in a Hutchinson-Gilford progeria syndrome patient. A case report
    710. Aging and cancer: can mTOR inhibitors kill two birds with one drug?
    711. Theoretical Paper: Exploring Overlooked Natural Mitochondria-Rejuvenative Intervention: The Puzzle of Bowhead Whales and Naked Mole Rats
    712. General introduction: Epigenetic programming by Polycomb group (PcG) proteins throughout development
    713. Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia
    714. Basic Science of Breast Cancer in Older Patients
    715. Defective DSB repair correlates with abnormal nuclear morphology and is improved with FTI treatment in Hutchinson-Gilford progeria syndrome fibroblasts
    716. TOR signaling never gets old: aging, longevity and TORC1 activity
    717. Akt signaling maintains survival and proliferation in immature T cells and hematopoietic Stem cells
    718. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin
    719. CXCR4 and mobilization of hematopoietic precursors
    720. The regulation of mammary prolactin receptor metabolism by a retroviral envelope protein
    721. PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic
    722. The role of the homeobox gene Hhex in definitive hematopoietic progenitor proliferation and differentiation
    723. The importance of the telomere and telomerase syStem in hematological malignancies
    724. Anatomy and physiology of hematopoiesis
    725. Analysis of developmentally programmed changes in hematopoietic Stem cells
    726. The Role of BMP Signaling and Endoglin in Regulation of Hematopoiesis
    727. Large scale gene expression profiles of regenerating inner ear sensory epithelia
    728. Genetically determined syndromes associated with premature aging
    729. The regulation of self-renewal in hematopoietic regeneration and malignancy
    730. Dose adjustment and supportive care before and during treatment
    731. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia
    732. Gene expression profiling for adult human olfactory neuroepithelial-derived progenitors
    733. Growth-inhibiting N-substituted endogenous peptides
    734. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo
    735. Current status of retroviral vector mediated gene transfer into human hematopoietic Stem cells
    736. The DNA damage response: making it safe to play with knives
    737. Requirement of the transcription factor and onco-protein Gfil for the development and function of hematopoietic Stem cells and progenitor cells
    738. EZH2 is over-expressed in SCLC as a result of genomic deregulation of the Rb/E2F pathway.
    739. EZH2 depletion blocks the proliferation of colon cancer cells
    740. Identification and characterisation of novel haemopoietic gene products derived from murine embryonal Stem cells
    741. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies
    742. Laminopathies and A-type lamin-associated signalling pathways
    743. Control of mRNA Translation in Erythropoiesis
    744. Visualizing the dynamics of p21Waf1/Cip1 cyclin-dependent kinase inhibitor expression in living animals
    745. The role of the transcription factor 3 gene product E47 in multipotent hematopoietic Stem cells and progenitors
    746. Therapeutic Modulation of DNA Damage and Repair Mechanisms in Blood Cells
    747. Stromal cell –immune cell interactions
    748. Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis
    749. Therapy Approach of Neurodegenerative Disorders by Bone Marrow Stem Cells
    750. Aging and TOR: interwoven in the fabric of life
    751. DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies
    752. Mouse models in aging research
    753. Disposable end tidal carbon dioxide detectors.
    754. Transcription factors, chromatin and cancer
    755. T cell function in the aged: Lessons learned from animal models
    756. FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis
    757. A phase I/II trial of recombinant human interleukin‐6 in patients with aplastic anaemia
    758. Hyphal Development in Candida albicans Requires Two Temporally Linked Changes in Promoter Chromatin for Initiation and Maintenance
    759. Stress responses of human dermal fibroblasts exposed to zinc pyrithione
    760. Walking in old age and development of metabolic syndrome: the health, aging, and body composition study
    761. The latest waves in calcium signaling
    762. Leukemias: principles and practice of therapy
    763. Alterations in chromatin are associated with increases in collagen III expression in aging nephropathy
    764. Accelerated features of age-related bone loss in zmpste24 metalloproteinase-deficient mice
    765. Embryonic senescence and laminopathies in a progeroid zebrafish model
    766. Mitochondrial ROS Generation and Its Regulation: Mechanisms Involved in H2O2 Signaling
    767. The investigation of macrophage inflammatory protein-1α as a myeloprotective agent
    768. A panel of monoclonal antibodies against human polycomb group proteins
    769. Effects of caloric restriction on cell proliferation in several tissues in mice: role of intermittent feeding
    770. The Hematopoietic Microenvironment
    771. 752Tissue Regeneration and Wound Healing
    772. Duchenne muscular dystrophy gene therapy: Lost in translation?
    773. Regulation of immune responses and hematopoiesis by the Rap1 signal
    774. Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo model for genetically transferred chemoprotection
    775. Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors
    776. Genetic and pharmacologic regulation of cyclin dependent kinase 4 and 6 activity in mammalian hematopoiesis
    777. Physical activity and telomere biology: exploring the link with aging-related disease prevention
    778. Hypertension, obesity, and inflammation: the complex designs of a deadly trio
    779. 13 Aging and Intrinsic Aging: Pathogenesis and Manifestations
    780. Postgraduate haematology
    781. Gene transfer of multidrug resistance into a factor-dependent human hematopoietic progenitor cell line: in vivo…
    782. Bridging the gap between clinical trials of antiplatelet therapies and applications among elderly patients
    783. The effect of vascular aging on cancer progression and metastasis
    784. PI3K/mTOR signaling regulates prostatic branching morphogenesis
    785. Pancytopenia and the hypocellular bone marrow
    786. Workshop on immunizations in older adults: identifying future research agendas
    787. Early Blood cell Formation
    788. The role of the histone methyltransferase egg/dSETDB1 in Drosophilia development and oogenesis
    789. Hematologic Disorders in the Elderly
    790. Fragments of functional proteins: role in endocrine regulation
    791. Cytokine regulation of hematopoietic Stem cells and lymphopoiesis
    792. Effects of white adipose tissue grafts on total body fat and cellularity are dependent on graft type and location
    793. Spontaneous abrogation of the G2 DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients
    794. Biodegradabable [sic] endovascular stents: fulfilling the mission and then stepping away
    795. Analysis of murine mammary epithelial cellular hierarchy
    796. Chemoprotection by transfer of resistance genes
    797. Statin’s excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling
    798. Distinct Roles of Cellular Copper and Erythropoietin Receptor on Hematopoietic Engraftment
    799. Lehrstuhl für Entwicklungsgenetik
    800. The role of the TSC-mTOR pathway on the regulation of the hematopoietic Stem cells
    801. Characterization of perforin and Fas ligand effector and regulatory T cell functions in allogeneic bone marrow transplantation
    802. G1 phase control and cell differentiation
    803. The effects of physiological adaptations to calorie restriction on global cell proliferation rates
    804. Programmed cell Death and Its Role in Neurological Disease
    805. PI3K𝛅 Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
    806. Handbook of Experimental Pharmacology
    807. Telomeres: hallmarks of radiosensitivity
    808. The role of telomerase in age-related degenerative disease and cancer
    809. Animal models of human genetic diseases: do they need to be faithful to be useful?
    810. The role of mTOR signaling in controlling mammalian life span: what a fungicide teaches us about longevity
    811. DNA Damage
    812. The Influence of MIP-1α and Its Receptors in Haemopoiesis
    813. Chromatin structure regulation in transforming growth factor-β-directed epithelial-mesenchymal transition
    814. Regulation of Stem cells and neurogenesis in the adult olfactory epithelium
    815. Identification, isolation and ex vivo expansion of haemopoietic progenitor and Stem cells
    816. Polycomb group protein Ezh2 regulates pancreas regeneration and neoplasia
    817. Mouse models for understanding the molecular mechanism of bone disease in Hutchinson-Gilford progeria syndrome
    818. Double Strand Break Signaling in Health and Diseases
    819. Bibliography Current World Literature Vol 14 No 4 July 2007
    820. CLINICAL RESEARCH PROJECT
    821. Telomere length and dynamics in Hutchinson-Gilford progeria syndrome
    822. Effects of Physiologic, Metabolic and Molecular Adaptations to Calorie Restriction on Biomarkers of Longevity
    823. Roles for E2F in mouse hematopoiesis and pancreas homeostasis
    824. 1 3 Hematopoietic Growth Factors
    825. The role of the RhoA/rho-kinase pathway in pulmonary hypertension
    826. Osteogenesis imperfecta
    827. Genomic approaches for pathway identification in regenerating sensory epithelia of the inner ear
    828. Les syndromes lipodystrophiques: des adipopathies congénitales ou acquises
    829. Nuclear lamins: major factors in the structural organization and
    830. International Workshop” From Homo sapiens to Homo sapiens liberatus
    831. cell cycle and cancer: the G1 restriction point and the G1/S transition
    832. TO ALLOMETRY AND SURVIVORSHIP
    833. The Role of CDKs in Normal and Neoplastic Proliferation
    834. Mechanisms of Gfi-1 mediated transcriptional repression
    835. Non-integrating integrase and long terminal repeat attachment site mutant HIV-1-derived lentiviral vectors
    836. Cancer Genome and DNA Repair
    837. Cancer, Senescence, and Aging: Translation from Basic Research to Clinics
    838. hGTSE-1 Protein Unveils a New Pathway that Regulates p21CIP1/WAF1 Stability and Subcellular Localization
    839. Role of the Transcription Factor Zfx in T cell Homeostasis
    840. Phospho-regulation of the DNA Damage Response Kinase ATR
    841. Spatial, temporal and reversible regulation of endogenous genes in vivo using RNA interference
    842. Genetic studies of familial myeloproliferative disorders
    843. Accelerated aging in COPD: the relationship of telomere length and mortality in COPD
    844. Investigations of Polyamine Function Using Transgenic Mouse Models with Spermidine Synthase and S-adenosylmethionine Decarboxylase Overexpression
    845. hGTSE1 protein unveils new pathways that regulate apoptosis and cell motility
    846. DNA sequence and chromatin directed compartmentalization of chromosomal domains to the nuclear lamina
    847. Role of the MUTYH protein in the response to oxidative damage to DNA
    848. Characterisation of the role of the transcription factor Gfi-1B in haematopoiesis
    849. JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 33 (4): 474-482, 2006 UMCG Disciplinegroep: NUC Annovazzi, A., Bonanno, E., Arca, M., D’ …
    850. The effect of maternal malaria during pregnancy on birth size, early childhood growth and blood pressure in Nigerian children
    851. Macrophage Inflammatory Protein-1&alpha: An Inhibitor of Clonogenic Epidermal Keratinocyte Proliferation?
    852. CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and Stem cell exhaustion
    853. Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult Stem cell exhaustion
    854. Loss of aryl hydrocarbon receptor promotes gene changes associated with premature hematopoietic Stem cell exhaustion and development of a myeloproliferative …
    855. C/EBPβ promotes BCR–ABL-mediated myeloid expansion and leukemic Stem cell exhaustion
    856. Age-specific bone tumour incidence rates are governed by Stem cell exhaustion influencing the supply and demand of progenitor cells
    857. Control of the epithelial Stem cell epigenome: the shaping of epithelial Stem cell identity
    858. aPKCλ controls epidermal homeostasis and Stem cell fate th